Exchange: NASDAQ·Updated 07:42 PM EST

RDNT News

News
all
press releases
RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
More News
Deal Dispatch: DoorDash Buys Instacart For $17B, Thrive Holdings Acquires ADT, SalesForce Nabs Rune Technologies
Major M&A deals this week include: Blue Matter buys Cognite, RadNet acquires ONRAD, Oak Hill Capital buys Wyyerd.read more...
Benzinga
Here's How Much You Would Have Made Owning RadNet Stock In The Last 15 Years
RadNet (NASDAQ:RDNT) has outperformed the market over the past 15 years by 12.77% on an annualized basis producing an average annual return of 25.97%. Currently, RadNet has a market capitalization of $5.63 billion.read more...
Benzinga
The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?
The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised
RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
Zacks
RadNet (RDNT) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for RadNet (RDNT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical (OM) delivered earnings and revenue surprises of -26.98% and +9.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Countdown to RadNet (RDNT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Zacks
Encompass Health (EHC) Beats Q2 Earnings and Revenue Estimates
Encompass Health (EHC) delivered earnings and revenue surprises of +4.73% and +1.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
Zacks

Advertisement|Remove ads.